Skip to main content
. 2015 Apr 24;10(4):e0124244. doi: 10.1371/journal.pone.0124244

Fig 5. Pharmacological distribution diagram for natural β-catenin inhibitors obtained using the DF3 (the black color represents natural β-catenin inhibitors and the white color, the compounds without β-catenin inhibition activity).

Fig 5